- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Fas ligand (FASLG) is a type II transmembrane protein belonging to the tumor necrosis factor ligand superfamily and is commonly referred to as CD95L or TNFSF6. Fas ligand (FASLG) functions as a key regulator of the extrinsic apoptotic pathway through binding to its receptor Fas (CD95), initiating caspase activation and programmed cell death in target cells. Fas Ligand Antibody / Microarray Specificity Validated Antibody enables detection of this critical immune effector molecule in lymphoid tissues and disease models where apoptosis signaling is active. FASLG is predominantly expressed by activated T lymphocytes and natural killer cells, with strong expression in lymphoid organs such as tonsil, lymph node, and spleen, where it contributes to immune surveillance and the maintenance of peripheral tolerance.
Fas ligand antibody, also known as FASLG antibody or CD95L antibody, recognizes a protein that exists in both membrane-bound and soluble forms, the latter generated through metalloprotease-mediated cleavage. The membrane-bound form is primarily responsible for inducing apoptosis through Fas receptor engagement, while the soluble form can modulate immune responses depending on cellular context. FASLG localizes to the plasma membrane and cytoplasmic vesicles of activated immune cells and is often detected in regions of active lymphocyte interaction. Its tightly regulated expression is essential for eliminating autoreactive lymphocytes and terminating immune responses, while dysregulation has been associated with autoimmune disease, chronic inflammation, and tumor immune escape mechanisms.
This Fas Ligand Antibody / Microarray Specificity Validated Antibody is supported by protein microarray analysis against more than 19,000 full-length human proteins, providing strong evidence of selective target recognition. In this assay, FASLG is identified as the top-ranked protein with a high Z score and a large separation from secondary signals, resulting in a robust S score that supports specificity. The Z score reflects the relative signal intensity compared to the array-wide mean, while the S score quantifies the separation between the intended target and the next highest binding proteins. This performance profile indicates preferential recognition of FASLG with minimal off-target interaction under the tested conditions, making this antibody well suited for applications where specificity is critical.
At the molecular level, FASLG belongs to the TNF ligand family and contains a conserved extracellular domain that mediates trimerization and receptor binding, which are required for efficient Fas activation. Upon engagement of Fas, the death-inducing signaling complex (DISC) is assembled, leading to activation of initiator caspases such as caspase-8 and downstream executioner caspases that drive apoptosis. This pathway is central to cytotoxic T cell and natural killer cell function, enabling the targeted elimination of infected or transformed cells. In addition, FASLG contributes to immune privilege in tissues such as the eye and testis, where its expression can limit inflammatory damage by inducing apoptosis in infiltrating immune cells.
FASLG expression is frequently observed in lymphoid tissue microenvironments characterized by active immune cell turnover, consistent with immunohistochemistry staining patterns showing cytoplasmic and membranous signal in lymphocytes within tonsillar tissue. In cancer, altered regulation of FASLG has been linked to immune evasion, where tumor cells may exploit Fas signaling to induce apoptosis in tumor-infiltrating lymphocytes. Conversely, reduced Fas pathway activity can contribute to resistance to apoptosis and tumor progression. Given its central role in apoptosis and immune regulation, combined with strong microarray-supported specificity, this antibody provides a valuable tool for investigating FASLG biology in immunology, oncology, and cell death research.
This antibody is part of a collection of Human Protein Microarray validated antibodies that have been screened for specificity across thousands of proteins.
Optimal dilution of the Fas Ligand Antibody / Microarray Specificity Validated Antibody should be determined by the researcher.
A portion of amino acids 107-222 from the human protein was used as the immunogen for the Fas Ligand antibody.
Store the Fas Ligand antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Fas ligand antibody, FASLG antibody, CD95L antibody, TNFSF6 antibody, FasL antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.